Similar articles

• Letter: irritable bowel syndrome-type symptoms in paediatric inflammatory bowel disease.

  Dai C, Jiang M, Sun MJ. Dai C, et al. Aliment Pharmacol Ther. 2016 Aug;44(3):308-9. doi: 10.1111/apt.13680. Aliment Pharmacol Ther. 2016. PMID: 27375101 No abstract available.
• The prevalence of irritable bowel syndrome-type symptoms in paediatric inflammatory bowel disease, and the relationship with biochemical markers of disease activity.

  Diederen K, Hoekman DR, Hummel TZ, de Meij TG, Koot BG, Tabbers MM, Vlieger AM, Kindermann A, Benninga MA. Diederen K, et al. Aliment Pharmacol Ther. 2016 Jul;44(2):181-8. doi: 10.1111/apt.13636. Epub 2016 Apr 25. Aliment Pharmacol Ther. 2016. PMID: 27110920
• [Comparison of symptoms, laboratory parameters and illness perception in patients with irritable bowel syndrome and inflammatory bowel disease].

  Bor R, Balanyi Z, Farkas K, Bálint A, Rutka M, Szűcs M, Milassin Á, Szepes Z, Nagy F, Molnár T. Bor R, et al. Orv Hetil. 2015 Jun 7;156(23):933-8. doi: 10.1556/650.2015.30168. Orv Hetil. 2015. PMID: 26027601 Hungarian.
• Comparison of geographic distributions of Irritable Bowel Syndrome with Inflammatory Bowel Disease fail to support common evolutionary roots: Irritable Bowel Syndrome and Inflammatory Bowel Diseases are not related by evolution.

  Szilagyi A, Xue X. Szilagyi A, et al. Med Hypotheses. 2018 Jan;110:31-37. doi: 10.1016/j.mehy.2017.10.020. Epub 2017 Nov 2. Med Hypotheses. 2018. PMID: 29317064 Review.
• Prebiotics and probiotics in irritable bowel syndrome and inflammatory bowel disease in children.

  Guandalini S, Cernat E, Moscoso D. Guandalini S, et al. Benef Microbes. 2015;6(2):209-17. doi: 10.3920/BM2014.0067. Benef Microbes. 2015. PMID: 25391345 Review.